These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 15177532)

  • 1. Drug-Drug Interaction Between Cannabidiol, Cyclosporine, and Mycophenolate Mofetil: A Case Report.
    Cuñetti L; Oricchio F; Vázquez M; Peyraube R; Manzo L; Nalerio C; Curi L; Maldonado C
    Transplant Proc; 2024; 56(1):252-256. PubMed ID: 38212169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New progress of small-molecule drugs in the treatment of inflammatory bowel disease.
    Yao D; Ran Z
    Chin Med J (Engl); 2024 Mar; 137(5):556-558. PubMed ID: 38269487
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporine: hope for severe COVID-19?
    Pathania YS
    BMJ Support Palliat Care; 2021 Jan; ():. PubMed ID: 33455917
    [No Abstract]   [Full Text] [Related]  

  • 4. Pregnancy and medications for inflammatory bowel disease: An updated narrative review.
    Akiyama S; Steinberg JM; Kobayashi M; Suzuki H; Tsuchiya K
    World J Clin Cases; 2023 Mar; 11(8):1730-1740. PubMed ID: 36969991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Old Bridge to the Newer Biologics: Cyclosporine for Rescue Therapy in Acute Severe Ulcerative Colitis.
    Ashat D; Jain A; Weaver KN; Long MD; Herfarth HH; Barnes EL
    Dig Dis Sci; 2022 Dec; 67(12):5439-5443. PubMed ID: 36125593
    [No Abstract]   [Full Text] [Related]  

  • 6. An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis.
    Ferretti F; Cannatelli R; Monico MC; Maconi G; Ardizzone S
    J Clin Med; 2022 Apr; 11(9):. PubMed ID: 35566428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Looking for the best anti-colitis medicine: A comparative analysis of current and prospective compounds.
    Chumanevich AA; Chaparala A; Witalison EE; Tashkandi H; Hofseth AB; Lane C; Pena E; Liu P; Pittman DL; Nagarkatti P; Nagarkatti M; Hofseth LJ; Chumanevich AA
    Oncotarget; 2017 Jan; 8(1):228-237. PubMed ID: 27974688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive effect of extracts from leaves of Fraxinus Mandshurica Rupr.
    Chen Y; Xue G; Liu F; Gong X
    Bioengineered; 2017 May; 8(3):212-216. PubMed ID: 27533742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive phenolic compounds from Hydnora abyssinica A. Braun.
    Koko WS; Mesaik MA; Ranjitt R; Galal M; Choudhary MI
    BMC Complement Altern Med; 2015 Nov; 15():400. PubMed ID: 26553149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of prodrugs to inflammatory diseases of the gut.
    Oz HS; Ebersole JL
    Molecules; 2008 Feb; 13(2):452-74. PubMed ID: 18305431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of inflammatory bowel disease: a review of medical therapy.
    Kozuch PL; Hanauer SB
    World J Gastroenterol; 2008 Jan; 14(3):354-77. PubMed ID: 18200659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Perianal Fistula and Abscess: Crohn's and Non-Crohn's.
    Mardini HE; Schwartz DA
    Curr Treat Options Gastroenterol; 2007 Jun; 10(3):211-20. PubMed ID: 17547859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapamycin decreases leukocyte migration in vivo and effectively reduces experimentally induced chronic colitis.
    Farkas S; Hornung M; Sattler C; Guba M; Steinbauer M; Anthuber M; Herfarth H; Schlitt HJ; Geissler EK
    Int J Colorectal Dis; 2006 Dec; 21(8):747-53. PubMed ID: 16228179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical Therapy of Crohn's Disease.
    Dhillon S; Loftus EV
    Curr Treat Options Gastroenterol; 2005 Feb; 8(1):19-30. PubMed ID: 15625031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine, tacrolimus, and mycophenolate mofetil in the treatment of inflammatory bowel disease.
    Loftus CG; Egan LJ; Sandborn WJ
    Gastroenterol Clin North Am; 2004 Jun; 33(2):141-69, vii. PubMed ID: 15177532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of conventional immunosuppressive drugs in IBD.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Zippi M
    Dig Liver Dis; 2004 Nov; 36(11):766-80. PubMed ID: 15571009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil is superior in combination with tacrolimus compared to cyclosporine for immunosuppressive therapy after liver transplantation.
    Glanemann M; Klupp J; Langrehr JM; Platz KP; Schröer G; Raakow R; Stange B; Settmacher U; Bechstein WO; Neuhaus P
    Transplant Proc; 2001; 33(1-2):1069-70. PubMed ID: 11267194
    [No Abstract]   [Full Text] [Related]  

  • 19. Higher immunosuppressive efficacy of mycophenolate mofetil in combination with FK 506 than in combination with cyclosporine A.
    Glanemann M; Klupp J; Langrehr JM; Schröer G; Platz KP; Stange B; Settmacher U; Bechstein WO; Neuhaus P
    Transplant Proc; 2000 May; 32(3):522-3. PubMed ID: 10812095
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.